Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II
by
Wessells H, Levine N, Hadley ME, Dorr R, Hruby V
Section of Urology,
The University of Arizona College of Medicine,
Tucson, 85724, USA.
hwessels@u.arizona.edu
MA, USA.
Int J Impot Res 2000 Oct; 12 Suppl 4:S74-9

ABSTRACT

We review our experience with Melanotan II, a non-selective melanocortin receptor agonist, in human subjects with erectile dysfunction (ED). Melanotan II was administered to 20 men with psychogenic and organic ED using a double-blind placebo-controlled crossover design. Penile rigidity was monitored for 6 h using RigiScan. Level of sexual desire and side effects were reported with a questionnaire. In the absence of sexual stimulation, Melanotan II led to penile erection in 17 of 20 men. Subjects experienced a mean of 41 min Rigiscan tip rigidity>80%. Increased sexual desire was reported after 13/19 (68%) doses of Melanotan II vs 4/21 (19%) of placebo (P<0.01). Nausea and yawning were frequently reported side effects due to Melanotan II; at a dose of 0.025 mg/kg, 12.9% of subjects had severe nausea. We conclude that Melanotan II is a potent initiator of penile erection in men with erectile dysfunction. Our findings warrant further investigation of melanocortin agonists and antagonists on penile erection

Viagra
PT-141
Melanotan
Yohimbine
Amineptine
Apomorphine
Phentolamine
SSRIs and sex
The menopause
Female sexuality
The Coolidge Effect
Testosterone and sex
Designer aphrodisiacs
Drugs for impotent rabbits
Sexual heath: sildenafil (Viagra)
The pharmacology of penile erection

Refs
and further reading

HOME
HedWeb
Nootropics
cocaine.wiki
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family